RecruitingNAINTERVENTIONAL

Initial Standardized Global Review in Axial Spondyloarthritis

This study, called 'Initial Standardized Global Review in Axial Spondyloarthritis', aims to find out if providing a detailed review and education shortly after an axial spondyloarthritis diagnosis helps patients understand their condition better. Axial spondyloarthritis is a type of arthritis that mainly affects the spine and large joints. Participants will either receive this special review and education or continue with their usual care for one year. We'll compare how much each group learns about their disease using a special questionnaire. This research involves adult patients recently diagnosed and will help us understand better ways to support people living with this condition from the start.

At a glance

Status

Recruiting

Phase

Sponsor

Association de Recherche Clinique en Rhumatologie

Enrolment target

154

Start

12 May 2025

Estimated completion

01 May 2027

Axial Spondylarthritis (axSpA)

What is this study about?

This study is called the 'Initial Standardized Global Review in Axial Spondyloarthritis'. Its main goal is to see if giving people a special, thorough review and some education about their condition soon after they've been diagnosed with axial spondyloarthritis makes a real difference. Axial spondyloarthritis is a type of long-term arthritis that mainly affects joints in the spine and sometimes other joints and parts of the body.

We're testing if this early review and education helps people understand their condition better over a year, compared to those who receive the standard care. Understanding your condition can help you manage it better in the long run. The study involves different clinics, with some offering the new review and others continuing with their usual way of caring for patients.

By doing this study, we hope to find clearer evidence about the best ways to support people just after they've been diagnosed with axial spondyloarthritis. The results could help doctors and nurses across the UK provide even better care and information to future patients, helping them to live well with the condition.

Key takeaways

This study investigates early education for axial spondyloarthritis.
It compares a special review with usual care over one year.
The main goal is to improve patient understanding of their condition.
No new medications are involved in this study.
Participation requires being an adult recently diagnosed with axSpA.

Who may be eligible?

To join this study, you need to be an adult between 18 and 80 years old. You must have been diagnosed with axial spondyloarthritis by a rheumatologist (a doctor specialising in arthritis) within the last year before joining. You also need to be able to understand what's involved and complete all the study activities.

However, you can't take part if you've already had, or are planning to have in the next year, a special programme or review focused on teaching you about your condition or its treatments.

Also, if you have any other health conditions, either physical or mental, that might make it hard for you to understand the study, follow the plans, or which could affect the study's results (like severe depression or issues with alcohol/drugs), you wouldn't be able to join.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 18 and 80 years old?
Have you been diagnosed with axial spondyloarthritis by a rheumatologist within the last 12 months?
Have you NOT already received detailed education about your condition?
Are you able to understand and complete study activities?
Do you feel you have the capacity to stick with the treatment plan (education and care provided)?

Answer every question to see your result.

What does participation involve?

If you join this study, you'll be part of one of two groups: either you'll receive the 'intervention' group, which involves a special, detailed review and education about your axial spondyloarthritis; or you'll be in the 'usual care' group, meaning you'll receive the care your doctor normally provides. The study will last for one year.

The main thing we'll be looking at is how much you understand about your condition. This will be measured using a special questionnaire called the 'SPondyloArthritis Knowledge Questionnaire' (SPAKE). You'll complete this questionnaire when you start the study and again after 12 months. There won't be any new medication given as part of this study; it's focused purely on the effect of a specific review and education.

Potential risks and benefits

Taking part might help you understand your axial spondyloarthritis better, especially if you're in the group receiving the special review and education. This improved understanding could help you to manage your condition more effectively. As with any study, there's always a chance that you might not experience any direct benefits. The questionnaires are straightforward and should not cause any discomfort. All information you provide will be kept private. You are free to withdraw from the study at any time without giving a reason, and this will not affect your usual medical care.

Locations (21)

CHU Besançon - Hôpital Jean Minjoz
Verified postcode
Besançon, France· Not yet recruiting
CHU Bordeaux - Hôpital Pellegrin
Verified postcode
Bordeaux, France· Not yet recruiting
CHRU Brest - Hôpital de La Cavale Blanche
Verified postcode
Brest, France· Not yet recruiting
CHU Caen
Verified postcode
Caen, France· Recruiting
CHU Clermont-Ferrand - Hôpital Gabriel-Montpied
Verified postcode
Clermont-Ferrand, France· Active not recruiting
AP-HP - Hôpital Henri Mondor
Verified postcode
Créteil, France· Recruiting
CHD Vendée
Verified postcode
La Roche-sur-Yon, France· Active not recruiting
AP-HP - Hôpital Bicêtre
Verified postcode
Le Kremlin-Bicêtre, France· Recruiting
CH Le Mans
Verified postcode
Le Mans, France· Active not recruiting
GHICL - Hôpital Saint Philibert
Verified postcode
Lomme, France· Not yet recruiting
AP-HM - Hôpital St Marguerite
Verified postcode
Marseille, France· Active not recruiting
AP-HP - Hôpital Cochin
Verified postcode
Paris, France· Recruiting

Common questions

What is axial spondyloarthritis?

It's a long-term type of arthritis mainly affecting the spine, causing pain, stiffness, and sometimes affecting other joints or parts of the body.

What is the study trying to find out?

It wants to see if an early, detailed review and education helps people understand their axial spondyloarthritis better than usual care.

Will I get new medicine in this study?

No, this study is about information and support, not about testing new medications.

How long will I be in the study?

The study will last for one year.

What if I change my mind about participating?

You can withdraw from the study at any time, and your medical care will not be affected.

How to find out more

Anna Molto

anna.molto@aphp.fr +33158412576 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.